[1]
da Silva, F.C.; Ferreira, V.F. Natural naphthoquinones with great importance in medicinal chemistry. Curr. Org. Synth., 2016, 13, 334-371.
[2]
Salmon-Chemin, L.; Buisine, E.; Yardley, V.; Kohler, S.; Debreu, M.A.; Landry, V.; Sergheraert, C.; Croft, S.L.; Krauth-Siegel, R.L.; Davioud-Charvet, E. 2- and 3-substituted 1,4-naphthoquinone derivatives as subversive substrates of trypanothione reductase and lipoamide dehydrogenase from Trypanosoma cruzi: synthesis and correlation between redox cycling activities and in vitro cytotoxicity. J. Med. Chem., 2001, 44, 548-565.
[3]
Müller, T.; Johann, L.; Jannack, B.; Brückner, M.; Lanfranchi, D.A.; Bauer, H.; Sanchez, C.; Yardley, V.; Deregnaucourt, C.; Schrével, J.; Lanzer, M.; Schirmer, R.H.; Davioud-Charvet, E. Glutathione reductase-catalyzed cascade of redox reactions to bioactivate potent antimalarial 1,4-naphthoquinones-a new strategy to combat malarial parasites. J. Am. Chem. Soc., 2011, 133, 11557-11571.
[4]
Benites, J.; Valderrama, J.A.; Rivera, F.; Rojo, L.; Campos, N.; Pedro, M.; José Nascimento, M.S. Studies on quinones. Part 42: Synthesis of furylquinone and hydroquinones with antiproliferative activity against human tumor cell lines. Bioorg. Med. Chem., 2008, 16, 862-868.
[5]
Silva, M.N.; de Souza, M.C.B.V.; Ferreira, V.F.; Pinto, A.V.; Pinto, M.C.R.F.; Wardell, S.M.S.V.; Wardell, J.L. Synthesis of new aldehyde derivatives from β-lapachone and nor-β-lapachone. ARKIVOC, 2003, 156-168.
[6]
Yang, R.Y.; Kizer, D.; Wu, H.; Volckova, E.; Miao, X.S.; Ali, S.M.; Tandon, M.; Savage, R.E.; Chan, T.C.; Ashwell, M.A. Synthetic methods for the preparation of ARQ 501 (beta-Lapachone) human blood metabolites. Bioorg. Med. Chem., 2008, 16, 5635-5643.
[7]
Khong, H.T.; Dreisbach, L.; Kindler, H.L.; Trent, D.F.; Jeziorski, K.G.; Bonderenko, I.; Popiela, T.; Yagovane, D.M.; Dombal, G. A phase 2 study of ARQ 501 in combination with gemcitabine in adult patients with treatment naïve, unresectable pancreatic adenocarcinoma. J. Clin. Oncol., 2007, 25, 15017.
[9]
Cragg, G.M.; Grothaus, P.G.; Newman, D.J. New horizons for old drugs and drug leads. J. Nat. Prod., 2014, 77, 703-723.
[10]
da Costa, E.C.B.; Amorim, R.; da Silva, F.C.; Papa, M.P.; de Arruda, L.B.; Mohana-Borges, R.; Ferreira, V.F.; Tanuri, A.; da Costa, L.J.; Ferreira, S.B. Synthetic 1,4-pyran naphthoquinones are potent inhibitors of dengue virus replication. PLoS One, 2013, 8, e82504.
[11]
Moosophon, P.; Kanokmedhakul, S.; Kanokmedhakul, K.; Soytong, K. Prenylxanthones and a bicyclo[3.3.1]nona-2,6-diene derivative from the fungus Emericella rugulosa. J. Nat. Prod., 2009, 72, 1442-1446.
[12]
Hay, A.E.; Aumond, M.C.; Mallet, S.; Dumontet, V.; Litaudon, M.; Rondeau, D.; Richomme, P. Antioxidant xanthones from Garcinia vieillardii. J. Nat. Prod., 2004, 67, 707-709.
[13]
Hashim, N.; Rahmani, M.; Sukari, M.A.; Ali, A.M.; Alitheen, N.B.; Go, R.; Ismail, H.B. Two new xanthones from Artocarpus obtusus. J. Asian Nat. Prod. Res., 2010, 12, 106-112.
[14]
Jamison, J.M.; Krabill, K.; Hatwalkar, A.; Jamison, E.; Tsai, C.C. Potentiation of the antiviral activity of poly r(A-U) by xanthene dyes. Cell Biol. Int. Rep., 1990, 14, 1075-1084.
[15]
Evangelinou, O.; Hatzidimitriou, A.G.; Velali, E.; Pantazaki, A.A.; Voulgarakis, N.; Aslanidis, P. Mixed-ligand copper(I) halide complexes bearing 4,5-bis(diphenylphosphano)-9,9-dimethyl-xanthene and N-methylbenzothiazole-2-thione: Synthesis, structures, luminescence and antibacterial activity mediated by DNA and membrane damage. Polyhedron, 2014, 72, 122-129.
[16]
Yunnikova, L.P.; Gorokhov, V.Y.; Makhova, T.V.; Aleksandrova, G.A. Synthesis and Antimicrobial Activity of Amines with Azaxanthene Fragments. Pharm. Chem. J., 2013, 47, 139-141.
[17]
Azebaze, A.G.; Meyer, M.; Valentin, A.; Nguemfo, E.L.; Fomum, Z.T.; Nkengfack, A.E. Prenylated xanthone derivatives with antiplasmodial activity from Allanblackia monticola STANER L.C. Chem. Pharm. Bull. , 2006, 54, 111-113.
[18]
Zelefack, F.; Guilet, D.; Fabre, N.; Bayet, C.; Chevalley, S.; Ngouela, S.; Lenta, B.N.; Valentin, A.; Tsamo, E.; Dijoux-Franca, M.G. Cytotoxic and antiplasmodial xanthones from Pentadesma butyracea. J. Nat. Prod., 2009, 72, 954-957.
[19]
Laphookhieo, S.; Syers, J.K.; Kiattansakul, R.; Chantrapromma, K. Cytotoxic and antimalarial prenylated xanthones from Cratoxylum cochinchinense. Chem. Pharm. Bull. (Tokyo), 2006, 54, 745-747.
[20]
Djoufack, G.L.; Valant-Vetschera, K.M.; Schinnerl, J.; Brecker, L.; Lorbeer, E.; Robien, W. Xanthones, biflavanones and triterpenes from Pentadesma grandifolia (Clusiaceae): structural determination and bioactivity. Nat. Prod. Commun., 2010, 5, 1055-1060.
[21]
Poupelin, J.P.; Saint-Ruf, G.; Foussard-Blanpin, O.; Narcisse, G.; Uchida-Ernouf, G.; Lacroix, R. Synthesis and antiinflammatory properties of bis (2-hydroxy-1-naphthyl)methane derivatives I. Eur. J. Med. Chem., 1978, 13, 67-71.
[22]
Rewcastle, G.W.; Atwell, G.J.; Li, Z.A.; Baguley, B.C.; Denny, W.A. Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids. J. Med. Chem., 1991, 34, 217-222.
[23]
Niu, S.L.; Li, Z.L.; Ji, F.; Liu, G.Y.; Zhao, N.; Liu, X.Q.; Jing, Y.K.; Hua, H.M. Xanthones from the stem bark of Garcinia bracteata with growth inhibitory effects against HL-60 cells. Phytochemistry, 2012, 77, 280-286.
[24]
Lee, K.H.; Chai, H.B.; Tamez, P.A.; Pezzuto, J.M.; Cordell, G.A.; Win, K.K.; Tin-Wa, M. Biologically active alkylated coumarins from Kayea assamica. Phytochemistry, 2003, 64, 535-541.
[25]
Tao, S.J.; Guan, S.H.; Wang, W.; Lu, Z.Q.; Chen, G.T.; Sha, N.; Yue, Q.X.; Liu, X.; Guo, D.A. Cytotoxic polyprenylated xanthones from the resin of Garcinia hanburyi. J. Nat. Prod., 2009, 72, 117-124.
[26]
Diniz, T.F.; Pereira, A.C.; Capettini, L.S.A.; Santos, M.H.; Nagem, T.J.; Lemos, V.S.; Cortes, S.F. Mechanism of the vasodilator effect of mono-oxygenated xanthones: a structure-activity relationship study. Planta Med., 2013, 79, 1495-1500.
[27]
Rao, T.V.P.; Venkateswarlu, V. Chemical examination of embelia ribes-VI: Synthesis of some new methylene-bisbenzoquinones. Tetrahedron, 1964, 20, 2967-2970.
[28]
Tisseh, Z.N.; Azimi, S.C.; Mirzaei, P.; Bazgir, A. The efficient synthesis of aryl-5H-dibenzo[b,i]xanthene-5,7,12,14(13H)-tetraone leuco-dye derivatives. Dyes Pigments, 2008, 79, 273-275.
[29]
Tavakoli, H.R.; Moosavi, S.M.; Bazgir, A. ZrOCl2•8H2O as an efficient catalyst for the synthesis of dibenzo [b,i]xanthene-tetraones and fluorescent hydroxyl naphthalene-1,4-diones. Res. Chem. Intermed., 2015, 41, 3041-3046.
[30]
Chen, Y.; Wu, S.; Tu, S.; Li, C.; Shi, F. A simple procedure for the synthesis of benzoxanthene derivatives under microwave irradiation conditions. J. Heterocycl. Chem., 2008, 45, 931-934.
[31]
Shaterian, H.R.; Azizi, K.; Fahimi, N. Phosphoric acid supported on alumina (H3PO4/Al2O3) as an efficient and reusable catalyst for the one-pot synthesis of benzoxanthene pigments. Res. Chem. Intermed., 2014, 40, 1403-1414.
[32]
Shaterian, H.R.; Rigi, F. An efficient synthesis of quinazoline and xanthene derivatives using starch sulfate as a biodegradable solid acid catalyst. Res. Chem. Intermed., 2015, 41, 721-738.
[33]
Amini, M.M.; Fazaeli, Y.; Yassaee, Z.; Shahzad, F.; Ayoob, B. Polytungstozincate Acid: A new and efficient catalyst for the synthesis of xanthenes under solvent-free conditions. Open Catal. J., 2009, 2, 40-44.
[34]
Khaligh, N.G. Poly(4-vinylpyridinium) hydrogen sulfate: an efficient catalyst for the synthesis of xanthene derivatives under solvent-free conditions. Catal. Sci. Technol., 2012, 2, 2211-2215.
[35]
Liu, D.; Gao, J.; Li, L.; Zhou, S.; Xu, D. Silica-supported sodium hydrogen sulfate catalyzed synthesis of 13-aryl-12h-dibenzo[b,i]-xanthene-5,7,12,14(13h)-tetraones. Chem. Heterocycl. Compd., 2013, 49, 1370-1373.
[36]
Shaterian, H.R.; Sedghipour, M.; Mollashahi, E. Brønsted acidic ionic liquids catalyzed the preparation of 13-aryl-5H-dibenzo[b,i]xanthene-5,7,12,14(13H)-tetraones and 3,4-dihydro-1H-benzo[b]xanthene-1,6,11(2H,12H)-triones. Res. Chem. Intermed., 2014, 40, 1345-1355.
[37]
Bazgir, A.; Tisseh, Z.N.; Mirzaei, P. An efficient synthesis of spiro[dibenzo[b,i]xanthene-13,3′-indoline]-pentaones and 5H-dibenzo[b,i]xanthene-tetraones. Tetrahedron Lett., 2008, 49, 5165-5168.
[38]
Carneiro, P.F.; Pinto, M.C.F.R.; Marra, R.K.F.; Campos, V.R.; Resende, J.A.; Delarmelina, M.; Carneiro, J.W.; Lima, E.S.; da Silva, F.C.; Ferreira, V.F. Insight into and Computational Studies of the Selective Synthesis of 6H-Dibenzo[b,h]xanthenes. J. Org. Chem., 2016, 81, 5525-5537.
[39]
Ferreira, V.F.; Nicoletti, C.D.; Ferreira, P.G.; Futuro, D.O.; da Silva, F.C. Strategies for increasing the solubility and bioavailability of anticancer compounds: β-Lapachone and other naphthoquinones. Curr. Pharm. Des., 2016, 22, 5899-5914.
[40]
Cardoso, M.F.C.; Rodrigues, P.C.; Oliveira, M.E.I.M.; Gama, I.L.; da Silva, I.M.; Santos, I.O.; Rocha, D.R.; Pinho, R.T. Ferreira, V.F.; de Souza M.C.; da Silva, F. C.; Silva-Jr, F.P. Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines. Eur. J. Med. Chem., 2014, 84, 708-717.
[41]
Zancan, P.; Sola-Penna, M.; Furtado, C.M.; da Silva, D. Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol. Genet. Metab., 2010, 100, 372-378.
[42]
Spitz, G.A.; Furtado, C.M.; Sola-Penna, M.; Zancan, P. Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity. Biochem. Pharmacol., 2009, 77, 46-53.
[43]
Furtado, C.M.; Marcondes, M.C.; Sola-Penna, M.; de Souza, M.L.; Zancan, P. Clotrimazole Preferentially Inhibits Human Breast Cancer Cell Proliferation, Viability and Glycolysis. PLoS One, 2012, 7, e30462.
[44]
Boechat, N.; Ferreira, V.F.; Ferreira, S.B. M.L.G., Ferreira; F.C., da Silva; Bastos, M.M.; Costa, M.S.; Lourenço, M.C.; Pinto, A.C.; Krettli, A.U.; Aguiar, A.C.; Teixeira, B.M.; da Silva, N.V.; Martins, P.R.; Bezerra, F.A.; Camilo, A.L.; da Silva, G.P.; Costa, C.C. Novel 1,2,3-Triazole Derivatives for Use against Mycobacterium tuberculosis H37Rv (ATCC 27294). Strain. J. Med. Chem., 2011, 54, 5988-5999.
[45]
da Silva, I.F.; Martins, P.R.C.; da Silva, E.G.; Ferreira, S.B.; Ferreira, V.F.; da Costa, K.R.; de Vasconcellos, M.C.; Lima, E.S.; da Silva, F.C. Synthesis of 1H-1,2,3-triazoles and Study of their Antifungal and Cytotoxicity Activities. Med. Chem., 2013, 9, 1085-1090.
[46]
Gao, S.Y.; Gong, Y.F.; Sun, Q.J.; Bai, J.; Wang, L.; Fan, Z.Q.; Sun, Y.; Su, Y.J.; Gang, J.; Ji, Y.B. Screening antitumor bioactive fraction from Sauromatum giganteum (Engl.) Cusimano & Hett and sensitive cell lines with the serum pharmacology method and identification by UPLC-TOF-MS. Molecules, 2015, 20, 4290-4306.
[47]
Zhang, N.; Guo, H.; Zheng, W.; Wang, T.; Ma, X. Design and screening of a chimeric survivin-specific nanobody and its anticancer activities in vitro. Anticancer Drugs, 2016, 27, 839-847.
[48]
Musumeci, D.; Amato, J.; Zizza, P.; Platella, C.; Cosconati, S.; Cingolani, C.; Biroccio, A.; Novellino, E.; Randazzo, A.; Giancola, C.; Pagano, B.; Montesarchio, D. Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes. Biochim. Biophys. Acta, 2017, 1861, 1341-1352.
[49]
Tam, K.F.; Ng, T.Y.; Tsang, P.C.; Li, C.F.; Ngan, H.Y. Potential use of the adenosine triphosphate cell viability assay in endometrial cancer. J. Soc. Gynecol. Investig., 2006, 13, 518-522.
[50]
Pointon, A.V.; Walker, T.M.; Phillips, K.M.; Luo, J.; Riley, J.; Zhang, S.D.; Parry, J.D.; Lyon, J.J.; Marczylo, E.L.; Gant, T.W. Doxorubicin in vivo rapidly alters expression and translation of myocardial electron transport chain genes, leads to ATP loss and caspase 3 activation. PLoS One, 2010, 5, e12733.
[51]
Bean, J.F.; Qiu, Y.Y.; Yu, S.; Clark, S.; Chu, F.; Madonna, M.B. Glycolysis inhibition and its effect in doxorubicin resistance in neuroblastoma. J. Pediatr. Surg., 2014, 49, 981-984.
[52]
Jones, L.J.; Gray, M.; Yue, S.T.; Haugland, R.P.; Singer, V.L. Sensitive determination of cell number using the CyQUANT cell proliferation assay. J. Immunol. Methods, 2001, 254, 85-98.
[53]
Lee, Y.; Oh, S.B.; Park, H.R.; Kim, H.S.; Kim, M.S.; Lee, J. Selective impairment on the proliferation of neural progenitor cells by oxidative phosphorylation disruption. Neurosci. Lett., 2013, 535, 134-139.
[54]
Park, W.H.; You, B.R. Antimycin A induces death of the human
pulmonary fibroblast cells via ROS increase and GSH depletion.
Int. J. Oncol., 2016, 48, 813-820.
77
5